Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines von Resch, I., Bruchbacher, A., Franke, J., Fajkovic, H., Remzi, M., Shariat, S.F., Schmidinger, M.

Volltext

DNA damage repair gene alteration status as a predictive marker for response to neoadjuvant chemotherapy in muscle invasive bladder cancer von Bruchbacher, A., Ilijazi, D., Hassler, M., Müllauer, L., Haitel, A., Baltzer, P., Ertl, I., Gust, K., Lemberger, U., Shariat, S.

Volltext

Hybrid thulium laser incision in bladder neck contracture: Surgical technique and early outcomes von Rosenbaum, C.M., Netsch, C., Becker, B., Filmar, S., Gross, A.J., Bruchbacher, A.

Volltext

V123 - Hybrid thulium laser incision in bladder neck contracture: Surgical technique and early outcomes von Rosenbaum, C.M., Netsch, C., Becker, B., Filmar, S., Gross, A.J., Bruchbacher, A.

Volltext

Assessment of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis von Hassler, M.R., Trimmel, B., Diemand, C., Oszwald, A., Ertl, I., Lemberger, U., Bruchbacher, A., Brettner, R., Compèrat, E., Shariat, S.F.

Volltext

Expression analysis and mutational status of histone methyltransferase KMT2D at different upper tract urothelial carcinoma locations von Laukhtina, E., Lemberger, U., Bruchbacher, A., Ilijazi, D., D’andrea, D., Susani, M., Enikeev, D., Shariat, S.F., Hassler, M.R.

Volltext

P060 - Prevalence of a polymorphic variant of HSD3B1 in benign and malignant prostate diseases and its prognostic value in castration-resistant prostate cancer von Stangl-Kremser, J., Lemberger, U., Hassler, M., Bruchbacher, A., Ilijazi, D., Abufaraj, M., Kramer, G., Haitel, A., Shariat, S.F.

Volltext

Prevalence of a polymorphic variant of HSD3B1 in benign and malignant prostate diseases and its prognostic value in castration-resistant prostate cancer von Stangl-Kremser, J., Lemberger, U., Hassler, M., Bruchbacher, A., Ilijazi, D., Abufaraj, M., Kramer, G., Haitel, A., Shariat, S.F.

Volltext

Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis von Mori, Keiichiro, Mostafaei, Hadi, Miura, Noriyoshi, Karakiewicz, Pierre I., Luzzago, Stefano, Schmidinger, Manuela, Bruchbacher, Andreas, Pradere, Benjamin, Egawa, Shin, Shariat, Shahrokh F.

Volltext

First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis von Quhal, Fahad, Mori, Keiichiro, Bruchbacher, Andreas, Resch, Irene, Mostafaei, Hadi, Pradere, Benjamin, Schuettfort, Victor M., Laukhtina, Ekaterina, Egawa, Shin, Fajkovic, Harun, Remzi, Mesut, Shariat, Shahrokh F., Schmidinger, Manuela

Volltext

Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis von Trimmel, Bettina, Oszwald, Andre, Diemand, Christoph, Ertl, Iris E., Lemberger, Ursula, Bruchbacher, Andreas, Brettner, Robert, Korn, Stephan, Resch, Irene, Comperat, Eva, Shariat, Shahrokh F., Hassler, Melanie R.

Volltext

Real-World Results of Cabozantinib Given as Alternative Schedule in Metastatic Renal Cell Carcinoma von Bruchbacher, Andreas, Franke, Johannes, Alimohammadi, Arman, Laukhtina, Ekaterina, Fajkovic, Harun, Schmidinger, Manuela

Volltext

Outcome with immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines von Bruchbacher, Andreas, Franke, Johannes, Alic, Zumreta, Nachbargauer, Sebastian, Fajkovic, Harun, Remzi, Mesut, Schmidinger, Manuela

Volltext

Sunitinib Rechallenge in Patients With Metastatic Renal Cell Carcinoma von Nachbargauer, Sebastian, Bruchbacher, Andreas, Fajkovic, Harun, Remzi, Mesut, Schmidinger, Manuela

Volltext

Alterations in DNA Damage Repair Genes Before and After Neoadjuvant Cisplatin-based Chemotherapy in Muscle-invasive Bladder Cancer von Lemberger, Ursula, Ernhofer, Büsra, Krieger, Sigurd, Bruchbacher, Andreas, Oszwald, André, Laukhtina, Ekaterina, Haitl, Andrea, Hassler, Melanie R., Englinger, Bernhard, Compérat, Eva, Shariat, Shahrokh F.

Volltext

Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound von Ertl, Iris E, Lemberger, Ursula, Ilijazi, Dafina, Hassler, Melanie R, Bruchbacher, Andreas, Brettner, Robert, Kronabitter, Hannah, Gutmann, Michael, Vician, Petra, Zeitler, Gerhard, Koren, Anna, Lardeau, Charles-Hugues, Mohr, Thomas, Haitel, Andrea, Compérat, Eva, Oszwald, André, Wasinger, Gabriel, Clozel, Thomas, Elemento, Olivier, Kubicek, Stefan, Berger, Walter, Shariat, Shahrokh F

Volltext

First-line treatment of metastatic renal cell carcinoma von Bruchbacher, Andreas, Netsch, Christopher, Gross, Andreas J

Volltext

Tissue biomarkers in nonmuscle-invasive bladder cancer: any role in clinical practice? von Bruchbacher, Andreas, Soria, Francesco, Hassler, Melanie, Shariat, Shahrokh F, D’Andrea, David

Volltext

Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer von Ilijazi, Dafina, Pulverer, Walter, Ertl, Iris E, Lemberger, Ursula, Kimura, Shoji, Abufaraj, Mohammad, D'Andrea, David, Pradere, Benjamin, Bruchbacher, Andreas, Graf, Anna, Soria, Francesco, Susani, Martin, Haitel, Andrea, Molinaro, Luca, Pycha, Armin, Comploj, Evi, Pabinger, Stephan, Weinhäusel, Andreas, Egger, Gerda, Shariat, Shahrokh F, Hassler, Melanie R

Volltext

Sunitinib Dose Escalation in Metastatic Renal Cell Carcinoma von Bruchbacher, Andreas, Nachbargauer, Sebastian, Fajkovic, Harun, Schmidinger, Manuela

Volltext